Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Published:2017-10 Issue:4 Volume:266 Page:667-676
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Boughey Judy C.,Ballman Karla V.,McCall Linda M.,Mittendorf Elizabeth A.,Symmans William Fraser,Julian Thomas B.,Byrd David,Hunt Kelly K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference36 articles.

1. Impact of neoadjuvant chemotherapy in stage ii-iii triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance);Golshan;Ann Surg,2015

2. Neoadjuvant chemotherapy for operable breast cancer;Mieog;Br J Surg,2007

3. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer;Kaufmann;Ann Surg Oncol,2012

4. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy;Kuerer;Ann Surg,1999

5. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27;Bear;J Clin Oncol,2003

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Top Ten Annals of Surgical Oncology Original Articles on Twitter/X: 2020–2023;Annals of Surgical Oncology;2024-08-13

2. FOXO4 suppresses cisplatin resistance of Triple-Negative Breast Cancer by inhibiting autophagy;The American Journal of the Medical Sciences;2024-08

3. Peroxiporins in Triple-Negative Breast Cancer: Biomarker Potential and Therapeutic Perspectives;International Journal of Molecular Sciences;2024-06-17

4. Predictive value of lymphocyte subsets and lymphocyte-to-monocyte ratio in assessing the efficacy of neoadjuvant therapy in breast cancer;Scientific Reports;2024-06-04

5. Axillary management in breast cancer after neoadjuvant chemotherapy in the modern era: A national cancer database analysis;Surgery;2024-03